脑部放疗，上午比下午敏感许多！7 Z! m/ C8 B/ @* C
, |" x6 t3 I1 F" e* @5 n
% f, A3 @# z# v6 ?Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
. L0 i* ^: X( j3 E: iGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
8 p) B: S, D; u0 ^, l0 KRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.) l$ H( g7 s3 T. p7 x$ ~9 w: N# A
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
6 |. ~4 h. x O( I" ~/ K/ @) F* L& }5 j0 B; j' w, s& `/ N* z
Abstract* C. `2 M) e0 ^9 T0 z3 W- L6 B6 H
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.2 y. d' Y: H3 D* R5 ^0 G
4 H/ {! d6 A( j/ P: ]
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
7 ]8 T; K! T9 y) r, Z
8 y7 k- r0 r, V/ q+ C1 m( S9 _RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026). {% l; a. [$ v" X& \3 J
+ b2 k% v/ P2 j, B# `" H7 eCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
: x/ B: c+ e" b% I' \# J" d8 ~8 `6 e7 y6 U$ ]" ], _8 l
|
$ c' s1 ^5 O9 f+ h# g& d
显身卡
